Skip to main content

Table 6 Type 2 diabetes (T2D) and adiposity

From: The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women

Type 2 diabetes

OR

SE

z

pvalue

95% CI

Model

     

Lower

Upper

pseudo-R 2

A

        
 

VAT

2.17

0.18

9.5

<2 × 10-16

1.85

2.54

0.07

DXA abdominal fat

1.86

0.13

8.6

<2 × 10-16

1.61

2.14

0.05

BMI

1.66

0.12

7.2

2 × 10-13

1.45

1.91

0.04

Age

1.05

0.01

4.3

8 × 10-6

1.03

1.07

0.02

B

        
 

VAT

2.08

0.18

8.5

<2 × 10-16

1.76

2.47

0.08

 

Age

1.02

0.01

2.0

0.05

1.00

1.05

 
  1. The study sample prevalence (females > = 40 years) estimate for T2D = 0.05. Logistic regressions (n = 2964) presenting unadjusted odds ratios (OR) (A) and best-fit multiple regression model with adjusted OR for visceral adipose fat (VAT) area and age (B). For evidence of the presented best-fit model and an analysis of residuals to account for co-linearity between adiposity variables, see Additional file 1: Tables S2 and S3, respectively. Explanatory variables VAT, DXA and BMI are all standardised, implying a change in odds ratio per unit SD change. For logistic regression, the pseudo-R 2 model-fit statistic is analogous (but not directly comparable) to the ordinary least squares regression R 2 statistic, known as the coefficient of determination. While R 2 can be interpreted as the proportion of variance explained by the model, pseudo-R 2 is loosely interpreted as the proportion of variation in risk liability explained by the model (StatCorp, Texas). Abbreviation: CI - confidence interval.